EACS takes steps towards a common, auditable European standard of care
Tackling HIV and hepatitis C in Europe: towards minimum standards
Glimmers of hope: moving towards better HIV and TB treatment in eastern Europe
Benefits of dolutegravir treatment for all substantially outweigh the risks
Stigma, access and testing: why HIV is still rising in Europe
Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds
Indonesia: tackling HIV in one of the world’s fastest-growing epidemics
Supervised drug consumption sites offer opportunities for HCV testing and treatment
Dolutegravir-based ART recommended for all – if reliable contraception is available
